PetIQ, Inc. 39L.F Stock
PetIQ, Inc. Price Chart
PetIQ, Inc. 39L.F Financial and Trading Overview
| PetIQ, Inc. stock price | 16.2 EUR |
| Previous Close | 13.5 EUR |
| Open | 13.8 EUR |
| Bid | 13.8 EUR x 0 |
| Ask | 14.1 EUR x 0 |
| Day's Range | 13.8 - 13.8 EUR |
| 52 Week Range | 6.9 - 17.7 EUR |
| Volume | 60 EUR |
| Avg. Volume | 3 EUR |
| Market Cap | 424.44M EUR |
| Beta (5Y Monthly) | 1.962323 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.06 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.4 EUR |
39L.F Valuation Measures
| Enterprise Value | 838.49M EUR |
| Trailing P/E | N/A |
| Forward P/E | 8.363637 |
| PEG Ratio (5 yr expected) | 0.95 |
| Price/Sales (ttm) | 0.4533168 |
| Price/Book (mrq) | 1.8162675 |
| Enterprise Value/Revenue | 0.896 |
| Enterprise Value/EBITDA | 11.46 |
Trading Information
PetIQ, Inc. Stock Price History
| Beta (5Y Monthly) | 1.962323 |
| 52-Week Change | -2.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 17.7 EUR |
| 52 Week Low | 6.9 EUR |
| 50-Day Moving Average | 11.06 EUR |
| 200-Day Moving Average | 9.94 EUR |
39L.F Share Statistics
| Avg. Volume (3 month) | 3 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 29.14M |
| Float | 24.1M |
| Short Ratio | N/A |
| % Held by Insiders | 0.95% |
| % Held by Institutions | 100.40% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -4.44% |
| Operating Margin (ttm) | 4.37% |
| Gross Margin | 22.88% |
| EBITDA Margin | 7.81% |
Management Effectiveness
| Return on Assets (ttm) | 2.86% |
| Return on Equity (ttm) | -17.34% |
Income Statement
| Revenue (ttm) | 936.29M EUR |
| Revenue Per Share (ttm) | 32.12 EUR |
| Quarterly Revenue Growth (yoy) | 5.40% |
| Gross Profit (ttm) | 209.66M EUR |
| EBITDA | 73.17M EUR |
| Net Income Avi to Common (ttm) | -41640000 EUR |
| Diluted EPS (ttm) | -1.32 |
| Quarterly Earnings Growth (yoy) | 209.79% |
Balance Sheet
| Total Cash (mrq) | 25.41M EUR |
| Total Cash Per Share (mrq) | 0.87 EUR |
| Total Debt (mrq) | 468.68M EUR |
| Total Debt/Equity (mrq) | 210.03 EUR |
| Current Ratio (mrq) | 2.133 |
| Book Value Per Share (mrq) | 7.598 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 50.08M EUR |
| Levered Free Cash Flow (ttm) | 40.46M EUR |
Profile of PetIQ, Inc.
| Country | Germany |
| State | ID |
| City | Eagle |
| Address | 230 East Riverside Drive |
| ZIP | 83616 |
| Phone | 208 939 8900 |
| Website | https://petiq.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1076 |
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
Q&A For PetIQ, Inc. Stock
What is a current 39L.F stock price?
PetIQ, Inc. 39L.F stock price today per share is 16.2 EUR.
How to purchase PetIQ, Inc. stock?
You can buy 39L.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PetIQ, Inc.?
The stock symbol or ticker of PetIQ, Inc. is 39L.F.
Which industry does the PetIQ, Inc. company belong to?
The PetIQ, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does PetIQ, Inc. have in circulation?
The max supply of PetIQ, Inc. shares is 29.2M.
What is PetIQ, Inc. Price to Earnings Ratio (PE Ratio)?
PetIQ, Inc. PE Ratio is 270.00003000 now.
What was PetIQ, Inc. earnings per share over the trailing 12 months (TTM)?
PetIQ, Inc. EPS is 0.06 EUR over the trailing 12 months.
Which sector does the PetIQ, Inc. company belong to?
The PetIQ, Inc. sector is Healthcare.